Mestanolone
![]() |
|
Clinical data | |
---|---|
Trade names | Andoron, Notandron |
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration |
Oral |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 99% oral |
Protein binding | yes |
Metabolism | Hepatic |
Biological half-life | ? |
Excretion | Renal |
Identifiers | |
|
|
Synonyms | (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-one |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
ECHA InfoCard | 100.007.549 |
Chemical and physical data | |
Formula | C20H32O2 |
Molar mass | 304.467 g/mol |
3D model (Jmol) | |
|
|
|
|
![]() ![]() |
Mestanolone (brand names Andoron, Notandron) is the 17α-methylated version of dihydrotestosterone (DHT).[1] The systematic name of mestanolone is: 17β-hydroxy-17α-methylandrost-3-one.[2] It is an orally bioavailable androgenic steroid that is highly androgenic while only slightly anabolic. It is incapable of aromatization and is not an agonist of the progesterone receptor.
Dosage Information
Dosages range from 10 mg to 30 mg a day for males. Women should avoid Mestanolone for it is very androgenic. Long-term use, more than 12 weeks, should be avoided do to hepatoxicity. Since Mestanolone is unable to convert to estrogen, it is very useful during cutting phases or when one wishes to avoid excess weight gain.
Synonyms
Mestanolone is also known as methylandrostanolone or 17alpha-methylandrostanolone.[3]
References[edit]
- ^ CTD (2007). "Chemicals: mestanolone". CTD - Comparative Toxicogenomics Database. Retrieved September 3, 2007.
- ^ Biology Online.org (2007). "mestanolone". Biology Online.org. Retrieved September 3, 2007.
- ^ "Compound Summary for CID 10633". Pubchem. Retrieved May 11, 2016.
![]() |
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |